| Trial ID: | L1208 |
| Source ID: | NCT06608212
|
| Associated Drug: |
Finerenone (Kerendia, Bay948862)
|
| Title: |
An Observational Study to Learn More About How Safe Finerenone is and How Well it Works in People With Chronic Kidney Disease and Type 2 Diabetes in Routine Medical Care in the United States
|
| Acronym: |
|
| Status: |
ACTIVE_NOT_RECRUITING
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Chronic Kidney Disease|Type 2 Diabetes Mellitus
|
| Interventions: |
DRUG: Finerenone (Kerendia, BAY948862)|DRUG: Others except finerenone
|
| Outcome Measures: |
Primary: Time to the first occurrence of composite cardiovascular outcome, The composite cardiovascular outcome includes an inpatient hospital diagnosis of fatal or nonfatal acute myocardial infarction or an inpatient hospitalisation with a primary diagnosis of heart failure., Retrospective analysis from July 2021 to June 2025 | Secondary: Time to the first occurrence of an inpatient hospital diagnosis of fatal or nonfatal acute myocardial infarction, Retrospective analysis from July 2021 to June 2025|Time to the first occurrence of an inpatient hospitalisation with a primary diagnosis of heart failure, Retrospective analysis from July 2021 to June 2025|Time to the first occurrence of an inpatient hospital or emergency department diagnosis of heart failure for participants without a history of heart failure, Retrospective analysis from July 2021 to June 2025|Time to occurrence of specific Urine Albumin-Creatine Ratio (UACR) decline thresholds, Retrospective analysis from July 2021 to June 2025|Time to the first occurrence of a hospitalisation or emergency department visit with a diagnosis code for hyperkalaemia, Retrospective analysis from July 2021 to June 2025
|
| Sponsor/Collaborators: |
Sponsor: Bayer
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
150000
|
| Study Type: |
OBSERVATIONAL
|
| Study Designs: |
Observational Model: |Time Perspective: p
|
| Start Date: |
2024-10-09
|
| Completion Date: |
2025-06-30
|
| Results First Posted: |
|
| Last Update Posted: |
2025-04-11
|
| Locations: |
Bayer, Whippany, New Jersey, 07981, United States
|
| URL: |
https://clinicaltrials.gov/show/NCT06608212
|
